Vision 2023 - The Future of Oral Cancer Treatment Market Transformations and Growth Opportunities

 Kathryn Stephens

Market Research Future Present’s “Global Oral Cancer Treatment Market Size, Status and Forecast 2023” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The report provides an extensive research and detailed analysis of the present market along with future outlook.

Global Oral Cancer Treatment Market: Highlights

Oral cancer or mouth cancer cab be referred to as the cancer of tongue, gums, throat, and others. Squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, and lymphomas are some of the common types of the oral cancer. Increasing prevalence of the oral cancer is the major driver for market growth during the forecast period. In 2017, according to the Oral Cancer Foundation, 49,750 Americans are estimated to be diagnosed with the oral oropharyngeal cancer. Moreover, it is estimated 9,750 deaths will be accounted for the same. Also, the rising per capita healthcare expenditures followed by growing awareness about oral diseases fuels the market growth.

In 2015, according to the Centres for Disease Control and Prevention, in the U.S., the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, risks for recurrence of cancer and high cost of treatment may restrain the market growth. According to the Dharamshila Hospital, New Delhi, India, in 2015, the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979.

The global oral cancer treatment market is expected to grow at an approximate CAGR of 7.1% during the forecast period.

Global Oral Cancer Treatment Market: Segmentation

The global oral cancer treatment market is segmented on the basis of type, treatment, and end users.

On the basis of type, the market is segmented into squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others.

On the basis of treatment, the market is segmented into surgery, radiotherapy, chemotherapy, and photodynamic therapy (PDT), and others. The surgery segment is sub segmented into tumor resection, glossectomy, laryngectomy, mohs micrographic surgery, and others. The chemotherapy segment is sub segmented into cisplatin, carboplatin, 5-fluorouracil (5-FU), and others.On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others.

Global Oral Cancer Treatment Market: Regional Analysis

America dominates the global oral cancer treatment market owing to the well-developed healthcare sector. Moreover, the presence of the global players like Bristol-Myers Squibb Company and Merck & Co., Inc. within the regional boundaries fuels the market growth.

Europe holds the second largest market for oral cancer treatment, which is followed by Asia Pacific. Huge patient population and a well-developed healthcare infrastructure will drive the market in the Europe. In 2014, according to the Cancer Research U.K, 11,449 new cases of oral cancer were reported which caused 2,386 estimated death within the same year.

Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India and China within the region. This along with favorable government policies, huge patient population and developing healthcare sector will boost the market growth within the region.

The Middle East & Africa has the least share in the global oral cancer treatment market due to presence of poor economies especially in the African region. Majority of the market of Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Get Premium Sample Copy @

Global Oral Cancer Treatment Market: Key Players

The key players for the global oral cancer treatment market are

  • Bristol-Myers Squibb Company (U.S.)
  • Qilu Pharmaceutical Co., Ltd. (Asia Pacific)
  • Teva Pharmaceutical Industries Ltd. (Isarael)
  • Eli Lilly and Company. (U.S.)
  • Hoffmann-La Roche Ltd (Europe)
  • Merck & Co., Inc. (U.S.)
  • Novartis AG (Europe)
  • Pfizer Inc. (U.S.)

Some Points form TOC for Oral Cancer Treatment Market Research:

  1. Report Prologue
  2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

  1. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

  1. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

…To be continued

Get Excusive Discount @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312


Domain: Business
Category: Sales & Marketing
Posted By: Kathryn Stephens and Contact Kathryn Stephens

Recent Press Releases

Suboxone Addiction Treatment - Here’...

It tends to be precarious to know whether you have an issue with Suboxone, or not. Truth be told, Suboxone was intentionally made so people don't trial or use Suboxone to get high.

23 March, 2019

American Investor Iconia Capital Ter...

The Republic of Georgia, a former member of the Soviet Union, has encouraged American investors to enter and help energize their economy. Unfortunately, this may just be theatrics

23 March, 2019

Elision Announced to Offer High Avai...

Elision Technolab LLP, more popularly known as Elision, is a leading VoIP company. The company offers the best call center solution which is developed with the top features. The ca

23 March, 2019